Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
49.9M
-
Shares change
-
-980K
-
Total reported value, excl. options
-
$941M
-
Value change
-
-$11.9M
-
Put/Call ratio
-
0.1
-
Number of buys
-
106
-
Number of sells
-
-114
-
Price
-
$18.84
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2024
285 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.9M shares
.
Largest 10 shareholders include BlackRock, Inc. (7.71M shares), VANGUARD GROUP INC (5.26M shares), Pacer Advisors, Inc. (3.26M shares), D. E. Shaw & Co., Inc. (2.26M shares), RENAISSANCE TECHNOLOGIES LLC (1.99M shares), STATE STREET CORP (1.97M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), Doma Perpetual Capital Management LLC (1.75M shares), MILLENNIUM MANAGEMENT LLC (1.49M shares), and UBS Group AG (1.37M shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.